Literature DB >> 7682532

The changing face of liver transplantation.

C Shorrock1, J Neuberger.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 7682532      PMCID： PMC1374130          DOI： 10.1136/gut.34.3.295

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  45 in total

1.  Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone.

Authors:  M Moran; M F Mozes; M S Maddux; S Veremis; C Bartkus; B Ketel; R Pollak; C Wallemark; O Jonasson
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

2.  Use of OKT3 in kidney, pancreas, and liver transplantation.

Authors:  A M D'Alessandro; J D Pirsch; J S Melzer; H W Sollinger; M Kalayoglu; A Reed; S J Knechtle; F O Belzer
Journal:  Transplant Proc       Date:  1990-08       Impact factor: 1.066

3.  Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.

Authors:  R E Morris; E G Hoyt; M P Murphy; E M Eugui; A C Allison
Journal:  Transplant Proc       Date:  1990-08       Impact factor: 1.066

4.  Deoxyspergualin for liver graft rejection.

Authors:  C G Groth; S Ohlman; B G Ericzon; L Barkholt; F P Reinholt
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

5.  Impact of Orthoclone OKT3 on liver transplantation.

Authors:  J J Fung; B H Markus; R D Gordon; C O Esquivel; L Makowka; A Tzakis; T E Starzl
Journal:  Transplant Proc       Date:  1987-04       Impact factor: 1.066

6.  Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report.

Authors:  S Iwatsuki; T E Starzl; S Todo; R D Gordon; C O Esquivel; A G Tzakis; L Makowka; J W Marsh; B Koneru; A Stieber
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

7.  Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history.

Authors:  P W Brunt; M C Kew; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1974-01       Impact factor: 23.059

8.  Anti-CD4 monoclonal antibody administration in renal transplanted patients.

Authors:  P Morel; C Vincent; G Cordier; G Panaye; E Carosella; J P Revillard
Journal:  Clin Immunol Immunopathol       Date:  1990-09

9.  The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats.

Authors:  D K Imagawa; J M Millis; K M Olthoff; P Seu; R A Dempsey; J Hart; P I Terasaki; E M Wasef; R W Busuttil
Journal:  Transplantation       Date:  1990-08       Impact factor: 4.939

10.  Liver, kidney, and thoracic organ transplantation under FK 506.

Authors:  S Todo; J J Fung; T E Starzl; A Tzakis; A J Demetris; R Kormos; A Jain; M Alessiani; S Takaya; R Shapiro
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.